Suzanne Clark, PhD

Department of Pharmaceutical and Biomedical Sciences
Chair and Associate Professor- Pharmaceutics

Phone: (916) 686-7376
Fax: (916) 686-8142
Suzanne.Clark@cnsu.edu


About

Suzanne Clark, RPh, PhD, is an Associate Professor of Pharmacology and Co-Director of the Center for Teaching and Learning. She received a BS from the University of Iowa, a Pharmacy BS from the University of Wyoming, and a PhD in Pharmacology from Duke University. Her publications have received 1932 citations (687 since 2013), with an h-index of 18 and an i10-index of 19, based on 19 peer-reviewed publications and 10 book chapters. She has been the P1/co-PI on 9 grants totalling over 160K. Her graduate research focused on in vitro models of epilepsy, anticonvulsant drug development, and glutamatergic/GABAergic processes, including contributing to the understanding of NMDA receptors in epileptogenesis and neurotoxic processes. Also while at Duke she worked as a hospital pharmacist and as a specialist at the Duke University Poison Control Center. She continued her post-doctoral research at the Durham Veterans Administration Medical Center/Duke University Medical Center, including helping to develop a funded Department of Defense Neurotoxicology Program Grant focused on military occupational exposures to neurotoxins and neurotoxic mechanisms. She completed postdoctoral work on AMPA receptors and chronic models of epilepsy at Colorado State University. She was an Assistant Professor of Pharmacology at the University of Wyoming School of Pharmacy, where she taught Pathophysiology to PharmD, Nursing, graduate and pre-professional students for nine years, was an affiliate faculty member in the Graduate Neuroscience Program, an original faculty member of the Biomedical Sciences PhD program, chaired and served on Masters and PhD committees, and held the Theodore O. and Dorothy S. King Endowed Professorship Agreement. Her research and scholarship focused on pharmacology, environmental toxicology, and occupational public health, the later for which she served on the Governor’s Task Force on Wyoming Workplace Fatality Prevention. She joined the CNU College of Pharmacy in 2014, where she teaches pharmacology and pathophysiology of the nervous system. Her current interests include neuropharmacology, public health, pharmacy education, and team-based learning.

Her national professional service includes being one of three core founding members who successfully submitted a proposal for the new Pharmacy Special Primary Interest Group (SPIG) within the 25K-member American Public Health Association (APHA). Within the APHA Pharmacy SPIG she has served as Secretary (2015-2016), Chair (2017), and is currently the immediate-Past Chair of the Pharmacy SPIG and Chair of the Policy Committee.

Peer-Reviews Publications

  • DiPietro Mager NA, Ochs L, Ranelli PL, Kahaleh AA, Lahoz MR, Patel RV, Garza OW, Isaacs D, Clark S, Partners in Public Health: Public Health Collaborations With Schools of Pharmacy, Public Health Reports. 2017;132 1-6 DOI: 10.1177/0033354917698126
  • Schilz JR, Reddy KJ, Nair S, Johnson TE, Tjalkens RB, Krueger KP, Clark S, Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability, J Vis Exp. 2015 Jun 21;(100):e52715. doi: 10.3791/52715. PMID: 26132311 PMCID: PMC4545071
  • Witter, RZ, Tenney L, Clark S, Newman LS, Occupational Exposures in the Oil and Gas Extraction Industry: State of the Science and Research Recommendations, American Journal of Industrial Medicine 2014;57:847-856. (https://onlinelibrary.wiley.com/doi/abs/10.1002/ajim.22316)
  • Witter, RZ, Tenney L, Clark S, Newman LS, Occupational Exposures in the Oil and Gas Extraction Industry: State of the Science and Research Recommendations, American Journal of Industrial Medicine 2014;57:847-856. (https://onlinelibrary.wiley.com/doi/abs/10.1002/ajim.22316)
  • Mahvan TD, Hornecker JR, Buckley WA, Clark S, The role of besifloxacin in the treatment of bacterial conjunctivitis., Annals of Pharmacotherapy, 2014;48:616-25.
  • Hua Y, Clark S, Ren J, Nair S., Molecular mechanisms of chromium in alleviating insulin resistance. J. Nutritional Biochem. 2012;23:313–319.
  • Williams PA, White, AM, Clark S, Ferraro DJ, Swiercz W, Staley KJ, Dudek FE, Development of spontaneous recurrent seizures after kainate-induced status epilepticus, J. Neurosci 2009;29:2103-2112
  • Wickenden AD, Krajewski JL, London B, Wagoner PK, Wilson WA, Clark S, Roeloffs R, McNaughton-Smith G, Rigdon GC, ICA-27243: A novel, selective KCNQ2/Q3 potassium channel activator. Molec Pharmacol. 2008;73:977-986.
  • Grabenstatter HL, Clark S, Dudek FE, Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols. Epilepsia 2007;(December) 48 (12), 2287–2295.
  • Jin R, Clark S, Weeks, AM, Dudman, JT, Gouaux E, Partin KM, Mechanism of positive allosteric modulators acting on AMPA receptors. J. Neurosci. 2005;25:9027- 9036.
  • Li Q, Clark S, Lewis DV, Wilson WA, (2002) MK-801, an NMDA receptor antagonist, modulates the inhibitory postsynaptic currents (IPSCs) in pyramidal neurons in rat cingulate/retrosplenial cortices. J. Neurosci. 2002;22(8): 3070-80.22(8).
  • Hosford, D.A., Clark, S., Cao, Z., Wilson, W.A., Lin, F.-H., Morrisett, R.A., and Huin, A. (1992) The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science 257: 398-401.
  • Stasheff, S.F., Anderson, W.W., Clark, S., and Wilson, W.A. (1989) NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science 245:648-651.

Selected Book Chapters:

  • Dudek FE, Clark S, Williams PA, Grabenstatter HL, (2006) Kainate-induced status epilepticus: A chronic model of acquired epilepsy, in: Models of Seizures and Epilepsy, Pitkanen, A., Schwartzkroin, P.A., and Moshe, S. (Eds.) Elsevier, Amsterdam, pp. 415-432.
  • Clark, S., and Wilson, W.A., (1999) Mechanisms of epileptogenesis. Advances in Neurolology,79: 607-30.; Clark S., Wilson W.A., and Delgado-Escueta, A.V. (1999) Epileptic cell damage and Epileptogenesis. Advances in Neurology, 79:735-6.
  • Clark, S., Stasheff, S. F., Lewis, D. V., Martin, D., Wilson, W. A. (1994) The NMDA receptor in epilepsy, In: The NMDA Receptor, 2nd Edition, J. C. Watkins and G. L. Collingridge, (Eds.), Oxford University Press, pp. 394-427.

Professional Awards and Honors:

  • 2018 CNUCOP Appreciation Award (22 May 2018)
  • 2018 AACP Walmart Scholars Mentor (Scholar: Vinna Nam, BS, PharmD Candidate, CO 2019)
  • 2017 CNU Presidential Letter of Commendation
  • 2017 CNUCOP Faculty Service Award
  • 2016 CNUCOP Faculty Service Award
  • 2015 2015 Top Reviewer, Research in Social and Administrative Pharmacy
  • 2014 AACP Walmart Scholars Mentor (Scholar: Greg Miller, BS, PharmD)
  • 2012 AACP Walmart Scholars Mentor (Scholar: Sara Lookabill, BS, PharmD)
  • 2012 Interprofessional Interdisciplinary Award, U. Wyoming CHS
  • 2012 Theodore O. and Dorothy S. King Endowed Professorship Agreement
  • 2010 Theodore O. and Dorothy S. King Endowed Professorship Agreement
  • 1999 Special Contribution Award (A6311) Dept. Veterans Affairs, Research

Graduate Awards and Honors:

  • 1989 Graduate School Conference Travel Grant, Duke University
  • 1988 Graduate & Professional Student Council, President’s Award, Duke Univ.
  • 1989 NIH Pharmacological Sciences Training Grant #302-4278, Duke Univ.

By partnering with PioneerRx Pharmacy Software, our program allows students to learn in a real-world environment using the most installed software for independent pharmacies. Students enhance their clinical and functional skills by training in a pharmacy system that is innovative, robust, and feature-rich.